| MNST |
Report |
Net Revenue (Q2 2026) |
BEAT |
pred ~$2.51B vs. cons $2.437B |
MEDIUM |
| MNST |
Report |
Gross Margin % (Q2 2026) |
MISS |
pred ~54.2% vs. cons ~54.5% implied |
MEDIUM |
| MNST |
Report |
EMEA Revenue (Q2 2026) |
BEAT |
pred ~$615M vs. cons $586M |
MEDIUM |
| MNST |
Guide |
FY 2026 Revenue tone (FY 2026) |
UNCHANGED |
guide reaffirm ~$9.6B vs. cons $9.589B |
HIGH |
| MNST |
Guide |
H2 Gross Margin trajectory (H2 2026) |
BETTER |
guide rate of increase moderating vs. cons flat H2 margin |
MEDIUM |
| MNST |
Guide |
July 2026 sales read / Q3 proxy (Q3 2026) |
BETTER |
guide ~+20-22% YoY vs. Q3 cons $2.446B (+11.3% YoY implied) |
MEDIUM |
| MNST |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| MNST |
Return |
5-day cumulative residual |
-0.5% (STABILIZE) |
STABILIZE — split-adjusted trading begins Aug 11, providing a technical bid; revenue beat drives modest FY estimate revisions upward but margin miss caps recovery |
MEDIUM |